Area of research
Surgery · Molecular Biology
Research interest
Research focused on Cancer research and Cancer, with related work in AMPK, Hepatocellular carcinoma, Reprogramming. Notable publications include 'Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation', 'Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy', and 'Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma'.
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma
One-step therapy strategy: Multifunctional chitosan-based hydrogel enriched with platelet-rich plasma for enhanced healing of infected wounds
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
Tangeretin Protects Mice from Alcohol-Induced Fatty Liver by Activating Mitophagy through the AMPK–ULK1 Pathway